2 active warrant series covering 4,298,000 shares (~9.3% potential dilution); nearest expiry 2028-03-18.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.20 | Mar 18, 2028 537d | 398K | OTM | 0.9% | C$80K | Auto |
| warrant | $0.25 | Mar 18, 2028 537d | 3.9M | OTM | 8.5% | C$975K | Auto |
Basis: Current shares & price vs as-filed warrant terms.
3 option grants covering 3,500,000 shares (~7.6% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.07 | Dec 30, 2028 824d | 1.4M | ITM | 3.0% | C$105K | Auto |
| option | $0.20 | Mar 27, 2029 911d | 400K | OTM | 0.9% | C$80K | Auto |
| option | $0.20 | Mar 27, 2031 1641d | 1.7M | OTM | 3.7% | C$340K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
46,129,920 shares outstanding, plus 4,298,000 from warrants and 3,500,000 from options — a fully diluted 53,927,920 shares, or ~16.9% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
2 active warrant series covering 4,298,000 shares (~9.3% potential dilution); nearest expiry 2028-03-18.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $0.20 | Mar 18, 2028 537d | 398K | OTM | 0.9% | C$80K | Auto |
| warrant | $0.25 | Mar 18, 2028 537d | 3.9M | OTM | 8.5% | C$975K | Auto |
Basis: Current shares & price vs as-filed warrant terms.
3 option grants covering 3,500,000 shares (~7.6% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $0.07 | Dec 30, 2028 824d | 1.4M | ITM | 3.0% | C$105K | Auto |
| option | $0.20 | Mar 27, 2029 911d | 400K | OTM | 0.9% | C$80K | Auto |
| option | $0.20 | Mar 27, 2031 1641d | 1.7M | OTM | 3.7% | C$340K | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
46,129,920 shares outstanding, plus 4,298,000 from warrants and 3,500,000 from options — a fully diluted 53,927,920 shares, or ~16.9% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
